Clinical Trial Update: Vaccine Therapy in Treating Patients With Malignant Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a vaccine therapy for malignant melanoma is underway. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: CancerVax Corporation | Conditions: Melanoma (Skin) | Phase 2 | Status: UNKNOWN